Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End User and Region - Global Forecasts to 2025
Updated on : February 17, 2023
The global cell expansion market in terms of revenue was estimated to be worth $14.9 billion in 2020 and is poised to reach $30.1 billion by 2025, growing at a CAGR of 15.1% from 2020 to 2025. Growth in this market is driven mainly by the increasing incidence of chronic diseases, government investments for cell-based research, the growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and growing GMP certifications for cell therapy production facilities.
Cell expansion Market Dynamics
Drivers: Increasing incidence of chronic diseases
Cell expansion is used in the R&D of drugs for the treatment of diseases. It is used in the production of vaccines, drugs, therapeutics, and antibiotics. The rising incidence of diseases such as diabetes and cancer has created a need for extensive research to develop new treatment options. According to the International Diabetes Federation (IDF), approximately 425 million people had diabetes in 2017, and this number is estimated to reach 629 million by 2045. Cancer, which has become the leading cause of death globally, accounted for 9.6 million deaths in 2018. According to GLOBOCAN, the number of cancer cases will rise to approximately 30 million by 2040 from 18 million in 2018. The growth in the prevalence of these diseases has resulted in a need to conduct extensive research for their diagnosis and treatment; cell expansion forms an important part of this research.
Restraints: Ethical concerns regarding research in cell biology
Research in cell biology necessitates the use of animals and humans, as animal and human cells are used in gene therapy studies that involve the recombination of genes and stem cell research therapies. These cells are also used for in vivo toxicity and pharmacokinetic testing of drugs, which may harm animals and humans. In addition, stem cell research studies use human embryos for clinical applications that often lead to the destruction of human embryos. To monitor these activities, strict regulations have been formulated by ethical authorities in various countries across the globe. Authorities such as the Human Tissue Authority (HTA), Human Fertilization and Embryology Authority (HFEA), Medicines and Healthcare products Regulatory Agency (MHRA), and Central Ethics Committee for Stem Cell Research (ZES), among others, have implemented stringent regulations for cell biology research. These ethical concerns and restrictions on the use of cells for research are limiting cell biology research to a great extent in various countries across the globe. This, in turn, is expected to restrict the growth of the global market.
Opportunities: Emerging markets
The emerging markets are expected to become a focal point for the growth of the global market. In the last few years, the biotechnology and pharmaceutical industries in countries such as India, Brazil, and China have grown significantly, and this trend is expected to continue during the forecast period. According to India Brand Equity Foundation (IBEF), the biotechnology industry in India is projected to reach USD 100 billion by 2025 from USD 11 billion in 2016, at a growth rate of 30.46%. According to the same source, the pharmaceutical industry in India is projected to reach USD 55 billion by 2020 from USD 36.7 billion in 2016. In Brazil, the pharmaceuticals market is expected to reach USD 29.9 billion by 2021 from USD 25.3 billion in 2016 (Source: Advantage Business Marketing). Growth in the biotechnology and pharmaceutical industries in these countries is expected to increase the demand for cell expansion products for R&D and the production of pharmaceutical products.
By product, the consumables segment accounted for the largest share of the cell expansion market.
Based on the product, the global market is segmented into consumables and instruments. The consumables segment is further segmented into reagents, media, sera, and disposables, while instruments are segmented into cell expansion supporting equipment, bioreactors, and automated cell expansion systems. In 2019, consumables accounted for the largest share of the cell expansion products market owing to the increasing production of vaccines and other biologics in the biopharmaceutical and biotechnology industries.
By application, the regenerative medicine and stem cell research segment accounted for the largest share of the global market.
Based on application, the market has been segmented into regenerative medicine and stem cell research, cancer & cell-based research, and others. The regenerative medicine and stem cell research segment accounted for the largest market share in 2019 due to the increased funding for regenerative medicine and stem cell research.
By cell type, the human cells segment accounted for the largest share of the cell expansion market.
Based on cell type, the global market is segmented into human cells and animal cells. The human cells segment includes stem cells and differentiated cells. The stem cells segment is further classified into adult stem cells, ESCs, and iPSCs. In 2019, the human cells segment accounted for the larger share of the global market, majorly due to the increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the growing incidence of diseases such as cancer.
North America accounted for the largest share of the cell expansion market.
North America accounted for the largest share of the global market in 2019. The large share of this segment can primarily be attributed to the rising incidence of cancer, increasing government funding, rising research activates on stem cell therapies, growing awareness regarding advanced treatment methods, growing geriatric population, and the strong presence of industry players in the region.
The global cell expansion market is dominated by a few globally established players such as Thermo Fisher Scientific (US), Danaher (US), Becton, Dickinson and Company (US), Lonza (Switzerland), Corning (US). Merck (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies Inc. (Canada), Sartorius Stedim Biotech (France), and Terumo (Japan). Start-up companies include REPROCELL (Japan), iXCells Biotechnologies (US), Neuromics (US), G&G technologies (US), and Celltainer Biotech (Netherlands).
Cell Expansion Market Report Scope:
Report Metric |
Details |
Market Size Available for Years |
2016–2025 |
Base Year Considered |
2019 |
Forecast Period |
2020–2025 |
Forecast Units |
Value (USD) |
Segments Covered |
Product, Cell Type, Application, End User, and Region |
Geographies Covered |
North America, Europe, APAC and the RoW |
Companies Covered |
The major market players include Thermo Fisher Scientific, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Lonza (Switzerland), Corning, Inc. (US), Merck KGaA (Germany), Sartorius Stedim Biotech (France), Getinge AB (Sweden) Terumo Corporation (Japan), and Miltenyi Biotec (Germany) |
The study categorizes the cell expansion market into the following segments and sub-segments:
By Product
-
Consumables
- Reagents
- Media
- Sera
-
Disposables
- Tissue Culture Flasks
- Bioreactor Accessories
- Other Disposables (Pipette Tubes, Petri Plates, Centrifuge Tubes, Cell Expansion Bags, and Filtration Membranes)
-
Instruments
-
Cell Expansion Supporting Equipment
- Flow Cytometers
- Centrifuges
- Cell Counters
- Other Supporting Equipment
-
Cell Expansion Supporting Equipment
-
Bioreactors
-
Microcarrier Bioreactors
- Microcarrier-based anchorage-dependent bioreactors
- Suspension-based anchorage-independent bioreactors
- Perfusion/Hollow Fibre Bioreactors
-
Microcarrier Bioreactors
- Automated Cell Expansion Systems
By Cell Type
-
Human Cells
- Stem Cells
-
Adult Stem Cells
- Induced Pluripotent Stem Cells
- Embryonic Stem Cells
- Differentiated Cells
- Animal Cells
By Application
- Regenerative Medicine and Stem Cell Research
- Cancer and Cell-based Research
- Other Applications (clinical studies, toxicology studies)
By End User
- Research Institutes
- Biotechnology and Biopharmaceutical Companies
- Cell Banks
- Other End Users (Hospitals and diagnostic laboratories)
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- China
- Japan
- India
- Singapore
- South Korea
- Rest of Asia Pacific
-
Rest of the World
- Latin America
- The Middle East and Africa
Recent Developments
- In 2020, Danaher acquired the Biopharma business from General Electric Company's Life Sciences division. The division will be known as Cytiva and act as a standalone operating company within Danaher's Life Sciences segment.
- In 2020, Eppendorf Group is expanding its production capacity at its Oldenburg, Holstein site in Germany. Due to the growing demand for consumables for COVID-19 research, the company will be manufacturing consumables made of high-quality plastic, such as pipette tips and tubes and single-use bioreactor vessels, at the newly expanded site.
- In 2020, Applikon Biotechnology entered into a partnership with Sotelab to strengthen its presence in the advanced cultivation systems market in South America.
- In 2019, Thermo Fisher Scientific invested around USD 24 million in its Inchinnan, Scotland site to expand global bio-production capabilities with additional large-volume liquid manufacturing capacity for cell culture media to meet growing customer demand.
Frequently Asked Questions (FAQ):
What is the current size of the global cell expansion market?
The global cell expansion market size is estimated to be USD 14.9 billion in 2020 and projected to reach USD 30.1 billion by 2025, at a CAGR of 15.1%.
Who are the leading players in the cell expansion market?
Some of the leading players in the cell expansion market include Thermo Fisher Scientific, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Lonza (Switzerland), Corning, Inc. (US), Merck KGaA (Germany), Sartorius Stedim Biotech (France), Getinge AB (Sweden) Terumo Corporation (Japan), and Miltenyi Biotec (Germany)
Who are the major end-users of the cell expansion market?
The end user of the cell expansion market includes research institutes, biotechnology & biopharmaceutical companies, cell banks, and other end-users such as hospitals, diagnostic centers, and laboratories. Biotechnology & biopharmaceutical companies are the largest end-users in the cell expansion market due to the increasing production of regenerative medicine, and rising awareness regarding advanced treatment methods such as personalized medicines and other cell-based therapies.
What are the major drivers of the cell expansion market?
Some of the major drivers of the cell expansion market include Increasing incidence of chronic diseases, government investments for cell-based research, growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 55)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKETS COVERED
FIGURE 1 CELL EXPANSION MARKET
1.2.2 COUNTRY COVERAGE
FIGURE 2 GLOBAL MARKET, BY REGION
1.2.3 YEARS CONSIDERED FOR THE STUDY
FIGURE 3 GLOBAL MARKET: YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 58)
FIGURE 4 RESEARCH DESIGN
2.1 SECONDARY DATA
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY DATA
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2.1 KEY DATA FROM PRIMARY SOURCES
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
FIGURE 6 GLOBAL MARKET: BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
FIGURE 7 GLOBAL MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 64)
FIGURE 9 CELL EXPANSION MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 10 GLOBAL MARKET, BY CELL TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 GLOBAL MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 12 GLOBAL MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 13 GLOBALMARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 68)
4.1 CELL EXPANSION MARKET OVERVIEW
FIGURE 14 INCREASING INCIDENCE OF CHRONIC DISEASES AND GOVERNMENT INVESTMENTS FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
4.2 NORTH AMERICA: MARKET, BY PRODUCT (2019)
FIGURE 15 CONSUMABLES COMMANDED THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019
4.3 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET
FIGURE 16 ASIA PACIFIC TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 71)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 CELL EXPANSION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
5.2.1 DRIVERS
5.2.1.1 Increasing incidence of chronic diseases
TABLE 1 GLOBAL PREVALENCE OF DIABETES, BY REGION (MILLION), 2000 VS. 2030
TABLE 2 RISING INCIDENCE OF CANCER, BY TYPE (MILLION)
5.2.1.2 Government investments for cell-based research
5.2.1.3 Growing focus on personalized medicine
TABLE 3 GROWTH IN THE NUMBER OF PERSONALIZED MEDICATIONS, 2008–2016
5.2.1.4 Increasing focus on R&D for cell-based therapies
TABLE 4 R&D EXPENDITURE BY PHARMACEUTICAL COMPANIES, 2016 VS. 2017
5.2.1.5 Increasing GMP certifications for cell therapy production facilities
TABLE 5 RISING REGULATORY APPROVALS FOR GMP TO BOOST THE MARKET
5.2.2 RESTRAINTS
5.2.2.1 Ethical concerns regarding research in cell biology
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 3D cell expansion technology
5.3 IMPACT OF COVID-19 ON THE GLOBAL MARKET
FIGURE 18 IMPACT OF COVID-19 ON THE GLOBAL MARKET
6 CELL EXPANSION MARKET, BY PRODUCT (Page No. - 78)
6.1 INTRODUCTION
TABLE 6 GLOBAL MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 7 GLOBAL MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
6.2 CONSUMABLES
TABLE 8 CELL EXPANSION CONSUMABLES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 9 CELL EXPANSION CONSUMABLES MARKET, BY REGION, 2020–2025 (USD MILLION)
TABLE 10 CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 11 CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
6.2.1 MEDIA
6.2.1.1 Media segment to dominate the cell expansion consumables market
TABLE 12 CELL EXPANSION CONSUMABLES MARKET FOR MEDIA, BY REGION, 2016–2019 (USD MILLION)
TABLE 13 CELL EXPANSION CONSUMABLES MARKET FOR MEDIA, BY REGION, 2020–2025 (USD MILLION)
6.2.2 REAGENTS
6.2.2.1 Reagents segment to account for the second-largest share of the cell expansion consumables market
TABLE 14 CELL EXPANSION CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2016–2019 (USD MILLION)
TABLE 15 CELL EXPANSION CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2020–2025 (USD MILLION)
6.2.3 SERA
6.2.3.1 North America to dominate the cell expansion sera market
TABLE 16 CELL EXPANSION CONSUMABLES MARKET FOR SERA, BY REGION, 2016–2019 (USD MILLION)
TABLE 17 CELL EXPANSION CONSUMABLES MARKET FOR SERA, BY REGION, 2020–2025 (USD MILLION)
6.2.4 DISPOSABLES
TABLE 18 CELL EXPANSION DISPOSABLES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 19 CELL EXPANSION DISPOSABLES MARKET, BY REGION, 2020–2025 (USD MILLION)
TABLE 20 CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 21 CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
6.2.4.1 Tissue culture flasks
6.2.4.1.1 Tissue culture flasks segment accounted for the largest share of the disposables market
TABLE 22 TISSUE CULTURE FLASKS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 23 TISSUE CULTURE FLASKS MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.4.2 Bioreactor accessories
6.2.4.2.1 Bioreactor accessories segment accounted for the second-largest share of the disposables market
TABLE 24 BIOREACTOR ACCESSORIES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 25 BIOREACTOR ACCESSORIES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.4.3 Other disposables
TABLE 26 OTHER DISPOSABLES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 27 OTHER DISPOSABLES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.3 INSTRUMENTS
TABLE 28 CELL EXPANSION INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 29 CELL EXPANSION INSTRUMENTS MARKET, BY REGION, 2020–2025 (USD MILLION)
TABLE 30 CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 31 CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
6.3.1 CELL EXPANSION SUPPORTING EQUIPMENT
TABLE 32 CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 33 CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
6.3.1.1 Flow cytometers
6.3.1.1.1 Product launches to drive the growth of this market segment
TABLE 34 FLOW CYTOMETERS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 35 FLOW CYTOMETERS MARKET, BY REGION, 2020–2025 (USD MILLION)
6.3.1.2 Centrifuges
6.3.1.2.1 Major players are focusing on launching new and advanced centrifuges in the market
TABLE 36 CENTRIFUGES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 37 CENTRIFUGES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.3.1.3 Cell counters & hemocytometers
6.3.1.3.1 Technological advancements supporting the growth of the cell counters & hemocytometers market
TABLE 38 CELL COUNTERS & HEMOCYTOMETERS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 39 CELL COUNTERS & HEMOCYTOMETERS MARKET, BY REGION, 2020–2025 (USD MILLION)
6.3.1.4 Other supporting equipment
TABLE 40 OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 41 OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2020–2025 (USD MILLION)
6.3.2 BIOREACTORS
TABLE 42 CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 43 CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
6.3.2.1 Microcarrier bioreactors
TABLE 44 MICROCARRIER BIOREACTORS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 45 MICROCARRIER BIOREACTORS MARKET, BY REGION, 2020–2025 (USD MILLION)
TABLE 46 MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 47 MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
6.3.2.1.1 Microcarrier-based anchorage-dependent bioreactors
6.3.2.1.1.1 Microcarrier-based anchorage-dependent bioreactors offer large-scale production
TABLE 48 MICROCARRIER-BASED ANCHORAGE-DEPENDENT BIOREACTORS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 49 MICROCARRIER-BASED ANCHORAGE-DEPENDENT BIOREACTORS MARKET, BY REGION, 2020–2025 (USD MILLION)
6.3.2.1.2 Suspension-based anchorage-independent bioreactors
6.3.2.1.2.1 North America is the largest market for suspension-based anchorage-independent bioreactors
TABLE 50 SUSPENSION-BASED ANCHORAGE-INDEPENDENT BIOREACTORS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 51 SUSPENSION-BASED ANCHORAGE-INDEPENDENT BIOREACTORS MARKET, BY REGION, 2020–2025 (USD MILLION)
6.3.2.2 Perfusion/hollow fiber bioreactors
6.3.2.2.1 Collaborations and product launches supporting the growth of this market segment
TABLE 52 PERFUSION/HOLLOW FIBER BIOREACTORS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 53 PERFUSION/HOLLOW FIBER BIOREACTORS MARKET, BY REGION, 2020–2025 (USD MILLION)
6.3.3 AUTOMATED CELL EXPANSION SYSTEMS
6.3.3.1 Technological advancements to drive the growth of this market segment
TABLE 54 AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY REGION, 2016–2019 USD MILLION)
TABLE 55 AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY REGION, 2020–2025 (USD MILLION)
7 CELL EXPANSION MARKET, BY CELL TYPE (Page No. - 101)
7.1 INTRODUCTION
TABLE 56 GLOBAL MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 57 GLOBAL MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
7.2 HUMAN CELLS
TABLE 58 HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 59 HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
7.2.1 STEM CELLS
TABLE 60 STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 61 STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
7.2.1.1 Adult stem cells
7.2.1.1.1 Adult stem cells segment accounts for the largest share of the human stem cells market, primarily due to increased government initiatives in cell-based research
TABLE 62 ADULT STEM CELLS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 63 ADULT STEM CELLS MARKET, BY REGION, 2020–2025 (USD MILLION)
7.2.1.2 Induced pluripotent stem cells
7.2.1.2.1 iPSCs are used in cell replacement therapies, drug screening, and tissue regeneration
TABLE 64 INDUCED PLURIPOTENT STEM CELLS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 65 INDUCED PLURIPOTENT STEM CELLS MARKET, BY REGION, 2020–2025 (USD MILLION)
7.2.1.3 Embryonic stem cells
7.2.1.3.1 Increasing private and public investments for stem cell research—major factor driving market growth
TABLE 66 ESCS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 67 ESCS MARKET, BY REGION, 2020–2025 (USD MILLION)
7.2.2 DIFFERENTIATED CELLS
7.2.2.1 Increasing prevalence of cancer is the major factor driving the growth of this market
TABLE 68 DIFFERENTIATED CELLS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 69 DIFFERENTIATED CELLS MARKET, BY REGION, 2020–2025 (USD MILLION)
7.3 ANIMAL CELLS
7.3.1 BIOPHARMACEUTICAL COMPANIES ARE THE MAJOR END USERS OF ANIMAL CELLS
TABLE 70 ANIMAL CELLS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 71 ANIMAL CELLS MARKET, BY REGION, 2020–2025 (USD MILLION)
8 CELL EXPANSION MARKET, BY APPLICATION (Page No. - 110)
8.1 INTRODUCTION
TABLE 72 GLOBAL MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 73 GLOBAL MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
8.2 REGENERATIVE MEDICINE AND STEM CELL RESEARCH
8.2.1 INCREASING GOVERNMENT FUNDING FOR REGENERATIVE MEDICINE AND STEM CELL RESEARCH TO DRIVE MARKET GROWTH
TABLE 74 GLOBAL MARKET FOR REGENERATIVE MEDICINE AND STEM CELL RESEARCH, BY REGION, 2016–2019 (USD MILLION)
TABLE 75 GLOBAL MARKET FOR REGENERATIVE MEDICINE AND STEM CELL RESEARCH, BY REGION, 2020–2025 (USD MILLION)
8.3 CANCER AND CELL-BASED RESEARCH
8.3.1 INCREASING PREVALENCE OF CANCER TO SUPPORT MARKET GROWTH
TABLE 76 GLOBAL MARKET FOR CANCER AND CELL-BASED RESEARCH, BY REGION, 2016–2019 (USD MILLION)
TABLE 77 GLOBAL MARKET FOR CANCER AND CELL-BASED RESEARCH, BY REGION, 2020–2025 (USD MILLION)
8.4 OTHER APPLICATIONS
TABLE 78 GLOBAL MARKET FOR OTHER APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
TABLE 79 GLOBAL MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2025 (USD MILLION)
9 CELL EXPANSION MARKET, BY END USER (Page No. - 115)
9.1 INTRODUCTION
TABLE 80 GLOBAL MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 81 GLOBAL MARKET, BY END USER, 2020–2025 (USD MILLION)
9.2 BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES
9.2.1 INCREASING INVESTMENTS IN CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
TABLE 82 GLOBAL MARKET FOR BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2016–2019 (USD MILLION)
TABLE 83 GLOBAL MARKET FOR BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020–2025 (USD MILLION)
9.3 RESEARCH INSTITUTES
9.3.1 GROWTH IN FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE THE MARKET FOR RESEARCH INSTITUTES
TABLE 84 GLOBAL MARKET FOR RESEARCH INSTITUTES, BY REGION, 2016–2019 (USD MILLION)
TABLE 85 GLOBAL MARKET FOR RESEARCH INSTITUTES, BY REGION, 2020–2025 (USD MILLION)
9.4 CELL BANKS
9.4.1 INCREASING AWARENESS AMONG PEOPLE ABOUT THE BENEFITS OF PRESERVING STEM CELLS TO DRIVE MARKET GROWTH
TABLE 86 GLOBAL MARKET FOR CELL BANKS, BY REGION, 2016–2019 (USD MILLION)
TABLE 87 GLOBAL MARKET FOR CELL BANKS, BY REGION, 2020–2025 (USD MILLION)
9.5 OTHER END USERS
TABLE 88 GLOBAL MARKET FOR OTHER END USERS, BY REGION, 2016–2019 (USD MILLION)
TABLE 89 GLOBAL MARKET FOR OTHER END USERS, BY REGION, 2020–2025 (USD MILLION)
10 CELL EXPANSION MARKET, BY REGION (Page No. - 121)
10.1 INTRODUCTION
TABLE 90 GLOBAL MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 91 GLOBAL MARKET, BY REGION, 2020–2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 19 NORTH AMERICA: CELL EXPANSION MARKET SNAPSHOT
TABLE 92 NORTH AMERICA: MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 93 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 94 NORTH AMERICA: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 95 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 96 NORTH AMERICA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 97 NORTH AMERICA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 98 NORTH AMERICA: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 99 NORTH AMERICA: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 100 NORTH AMERICA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 101 NORTH AMERICA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 102 NORTH AMERICA: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 103 NORTH AMERICA: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 104 NORTH AMERICA: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 105 NORTH AMERICA: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 106 NORTH AMERICA: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 107 NORTH AMERICA: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 108 NORTH AMERICA: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 109 NORTH AMERICA: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 110 NORTH AMERICA: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 111 NORTH AMERICA: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 112 NORTH AMERICA: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 113 NORTH AMERICA: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 114 NORTH AMERICA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 115 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 116 NORTH AMERICA: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 117 NORTH AMERICA: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.2.1 US
10.2.1.1 US to witness the highest growth in the North American cell expansion market due to the increasing government funding for cell-based research
TABLE 118 US: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 119 US: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 120 US: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 121 US: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 122 US: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 123 US: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 124 US: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 125 US: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 126 US: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 127 US: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 128 US: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 129 US: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 130 US: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 131 US: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 132 US: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 133 US: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 134 US: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 135 US: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 136 US: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 137 US: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 138 US: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 139 US: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 140 US: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 141 US: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing funding for research in regenerative medicine to support market growth in Canada
TABLE 142 CANADA: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 143 CANADA: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 144 CANADA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 145 CANADA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 146 CANADA: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 147 CANADA: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 148 CANADA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 149 CANADA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 150 CANADA: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 151 CANADA: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 152 CANADA: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 153 CANADA: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 154 CANADA: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 155 CANADA: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 156 CANADA: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 157 CANADA: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 158 CANADA: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 159 CANADA: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 160 CANADA: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 161 CANADA: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 162 CANADA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 163 CANADA: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 164 CANADA: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 165 CANADA: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.3 EUROPE
TABLE 166 EUROPE: CELL EXPANSION MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 167 EUROPE: MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 168 EUROPE: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 169 EUROPE: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 170 EUROPE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 171 EUROPE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 172 EUROPE: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 173 EUROPE: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 174 EUROPE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 175 EUROPE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 176 EUROPE: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 177 EUROPE: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 178 EUROPE: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 179 EUROPE: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 180 EUROPE: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 181 EUROPE: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 182 EUROPE: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 183 EUROPE: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 184 EUROPE: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 185 EUROPE: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 186 EUROPE: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 187 EUROPE: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 188 EUROPE: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 189 EUROPE: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 190 EUROPE: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 191 EUROPE: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany is the fastest-growing market for cell expansion in Europe
TABLE 192 GERMANY: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 193 GERMANY: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 194 GERMANY: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 195 GERMANY: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 196 GERMANY: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 197 GERMANY: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 198 GERMANY: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 199 GERMANY: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 200 GERMANY: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 201 GERMANY: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 202 GERMANY: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 203 GERMANY: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 204 GERMANY: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 205 GERMANY: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 206 GERMANY: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 207 GERMANY: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 208 GERMANY: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 209 GERMANY: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 210 GERMANY: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 211 GERMANY: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 212 GERMANY: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 213 GERMANY: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 214 GERMANY: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 215 GERMANY: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Robust biotechnology infrastructure in the country to support market growth
TABLE 216 FRANCE: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 217 FRANCE: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 218 FRANCE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 219 FRANCE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 220 FRANCE: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 221 FRANCE: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 222 FRANCE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 223 FRANCE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 224 FRANCE: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 225 FRANCE: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 226 FRANCE: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 227 FRANCE: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 228 FRANCE: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 229 FRANCE: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 230 FRANCE: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 231 FRANCE: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 232 FRANCE: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 233 FRANCE: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 234 FRANCE: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 235 FRANCE: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 236 FRANCE: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 237 FRANCE: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 238 FRANCE: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 239 FRANCE: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.3.3 UK
10.3.3.1 Government investments in stem cell research to drive the market for cell expansion in the UK
TABLE 240 UK: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 241 UK: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 242 UK: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 243 UK: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 244 UK: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 245 UK: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 246 UK: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 247 UK: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 248 UK: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 249 UK: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 250 UK: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 251 UK: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 252 UK: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 253 UK: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 254 UK: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 255 UK: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 256 UK: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 257 UK: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 258 UK: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 259 UK: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 260 UK: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 261 UK: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 262 UK: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 263 UK: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increasing number of cell biology seminars and conferences to fuel the adoption of cell expansion products
TABLE 264 ITALY: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 265 ITALY: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 266 ITALY: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 267 ITALY: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 268 ITALY: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 269 ITALY: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 270 ITALY: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 271 ITALY: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 272 ITALY: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 273 ITALY: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 274 ITALY: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 275 ITALY: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 276 ITALY: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 277 ITALY: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 278 ITALY: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 279 ITALY: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 280 ITALY: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 281 ITALY: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 282 ITALY: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 283 ITALY: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 284 ITALY: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 285 ITALY: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 286 ITALY: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 287 ITALY: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing funding from private and public organizations to aid market growth
TABLE 288 SPAIN: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 289 SPAIN: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 290 SPAIN: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 291 SPAIN: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 292 SPAIN: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 293 SPAIN: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 294 SPAIN: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 295 SPAIN: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 296 SPAIN: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 297 SPAIN: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 298 SPAIN: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 299 SPAIN: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 300 SPAIN: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 301 SPAIN: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 302 SPAIN: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 303 SPAIN: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 304 SPAIN: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 305 SPAIN: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 306 SPAIN: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 307 SPAIN: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 308 SPAIN: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 309 SPAIN: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 310 SPAIN: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 311 SPAIN: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 312 ROE: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 313 ROE: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 314 ROE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 315 ROE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 316 ROE: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 317 ROE: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 318 ROE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 319 ROE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 320 ROE: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 321 ROE: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 322 ROE: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 323 ROE: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 324 ROE: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 325 ROE: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 326 ROE: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 327 ROE: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 328 ROE: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 329 ROE: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 330 ROE: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 331 ROE: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 332 ROE: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 333 ROE: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 334 ROE: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 335 ROE: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.4 ASIA PACIFIC
TABLE 336 ASIA PACIFIC: CELL EXPANSION MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 337 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 338 ASIA PACIFIC: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 339 ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 340 ASIA PACIFIC: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 341 ASIA PACIFIC: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 342 ASIA PACIFIC: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 343 ASIA PACIFIC: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 344 ASIA PACIFIC: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 345 ASIA PACIFIC: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 346 ASIA PACIFIC: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 347 ASIA PACIFIC: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 348 ASIA PACIFIC: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 349 ASIA PACIFIC: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 350 ASIA PACIFIC: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 351 ASIA PACIFIC: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 352 ASIA PACIFIC: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 353 ASIA PACIFIC: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 354 ASIA PACIFIC: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 355 ASIA PACIFIC: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 356 ASIA PACIFIC: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 357 ASIA PACIFIC: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 358 ASIA PACIFIC: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 359 ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 360 ASIA PACIFIC: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 361 ASIA PACIFIC: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Growing geriatric population in the country to drive market growth
TABLE 362 JAPAN: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 363 JAPAN: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 364 JAPAN: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 365 JAPAN: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 366 JAPAN: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 367 JAPAN: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 368 JAPAN: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 369 JAPAN: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 370 JAPAN: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 371 JAPAN: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 372 JAPAN: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 373 JAPAN: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 374 JAPAN: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 375 JAPAN: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 376 JAPAN: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 377 JAPAN: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 378 JAPAN: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 379 JAPAN: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 380 JAPAN: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 381 JAPAN: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 382 JAPAN: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 383 JAPAN: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 384 JAPAN: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 385 JAPAN: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Government initiatives to promote stem cell research to play a major role in driving market growth
TABLE 386 CHINA: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 387 CHINA: CELL EXPANSION MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 388 CHINA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 389 CHINA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 390 CHINA: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 391 CHINA: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 392 CHINA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 393 CHINA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 394 CHINA: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 395 CHINA: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 396 CHINA: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 397 CHINA: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 398 CHINA: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 399 CHINA: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 400 CHINA: CELL EXPANSION MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 401 CHINA: CELL EXPANSION MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 402 CHINA: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 403 CHINA: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 404 CHINA: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 405 CHINA: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 406 CHINA: CELL EXPANSION MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 407 CHINA: CELL EXPANSION MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 408 CHINA: CELL EXPANSION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 409 CHINA: CELL EXPANSION MARKET, BY END USER, 2020–2025 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing pharmaceutical and biotechnology industries—key growth driver for the cell expansion market in India
TABLE 410 INDIA: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 411 INDIA: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 412 INDIA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 413 INDIA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 414 INDIA: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 415 INDIA: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 416 INDIA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 417 INDIA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 418 INDIA: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 419 INDIA: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 420 INDIA: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 421 INDIA: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 422 INDIA: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 423 INDIA: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 424 INDIA: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 425 INDIA: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 426 INDIA: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 427 INDIA: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 428 INDIA: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 429 INDIA: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 430 INDIA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 431 INDIA: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 432 INDIA: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 433 INDIA: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.4.4 SINGAPORE
10.4.4.1 Presence of leading pharmaceutical companies is supporting the growth of the cell expansion market in the country
TABLE 434 SINGAPORE: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 435 SINGAPORE: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 436 SINGAPORE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 437 SINGAPORE: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 438 SINGAPORE: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 439 SINGAPORE: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 440 SINGAPORE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 441 SINGAPORE: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 442 SINGAPORE: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 443 SINGAPORE: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 444 SINGAPORE: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 445 SINGAPORE: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 446 SINGAPORE: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 447 SINGAPORE: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 448 SINGAPORE: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 449 SINGAPORE: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 450 SINGAPORE: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 451 SINGAPORE: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 452 SINGAPORE: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 453 SINGAPORE: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 454 SINGAPORE: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 455 SINGAPORE: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 456 SINGAPORE: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 457 SINGAPORE: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Conferences and research activities on stem cells are supporting the growth of the cell expansion market in the country
TABLE 458 SOUTH KOREA: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 459 SOUTH KOREA: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 460 SOUTH KOREA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 461 SOUTH KOREA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 462 SOUTH KOREA: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 463 SOUTH KOREA: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 464 SOUTH KOREA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 465 SOUTH KOREA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 466 SOUTH KOREA: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 467 SOUTH KOREA: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 468 SOUTH KOREA: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 469 SOUTH KOREA: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 470 SOUTH KOREA: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 471 SOUTH KOREA: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 472 SOUTH KOREA: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 473 SOUTH KOREA: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 474 SOUTH KOREA: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 475 SOUTH KOREA: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 476 SOUTH KOREA: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 477 SOUTH KOREA: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 478 SOUTH KOREA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 479 SOUTH KOREA: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 480 SOUTH KOREA: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 481 SOUTH KOREA: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 482 ROAPAC: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 483 ROAPAC: CELL EXPANSION MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 484 ROAPAC: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2019–2019 (USD MILLION)
TABLE 485 ROAPAC: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 486 ROAPAC: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 487 ROAPAC: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 488 ROAPAC: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 489 ROAPAC: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 490 ROAPAC: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 491 ROAPAC: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 492 ROAPAC: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 493 ROAPAC: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 494 ROAPAC: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 495 ROAPAC: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 496 ROAPAC: CELL EXPANSION MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 497 ROAPAC: CELL EXPANSION MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 498 ROAPAC: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 499 ROAPAC: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 500 ROAPAC: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 501 ROAPAC: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 502 ROAPAC: CELL EXPANSION MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 503 ROAPAC: CELL EXPANSION MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 504 ROAPAC: CELL EXPANSION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 505 ROAPAC: CELL EXPANSION MARKET, BY END USER, 2020–2025 (USD MILLION)
10.5 ROW
TABLE 506 ROW: CELL EXPANSION MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 507 ROW: CELL EXPANSION MARKET, BY REGION, 2020–2025 (USD MILLION)
TABLE 508 ROW: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 509 ROW: CELL EXPANSION MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 510 ROW: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 511 ROW: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 512 ROW: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 513 ROW: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 514 ROW: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 515 ROW: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 516 ROW: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 517 ROW: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 518 ROW: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 519 ROW: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 520 ROW: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 521 ROW: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 522 ROW: CELL EXPANSION MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 523 ROW: CELL EXPANSION MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 524 ROW: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 525 ROW: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 526 ROW: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 527 ROW: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 528 ROW: CELL EXPANSION MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 529 ROW: CELL EXPANSION MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 530 ROW: CELL EXPANSION MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 531 ROW: CELL EXPANSION MARKET, BY END USER, 2020–2025 (USD MILLION)
10.5.1 LATIN AMERICA
10.5.1.1 Increasing incidence of cancer to drive the market for cell expansion
FIGURE 20 NUMBER OF NEW CANCER CASES IN LATIN AMERICA, 2018–2035
TABLE 532 LATIN AMERICA: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 533 LATIN AMERICA: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 534 LATIN AMERICA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 535 LATIN AMERICA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 536 LATIN AMERICA: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 537 LATIN AMERICA: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 538 LATIN AMERICA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 539 LATIN AMERICA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 540 LATIN AMERICA: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 541 LATIN AMERICA: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 542 LATIN AMERICA: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 543 LATIN AMERICA: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 544 LATIN AMERICA: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 545 LATIN AMERICA: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 546 LATIN AMERICA: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 547 LATIN AMERICA: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 548 LATIN AMERICA: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 549 LATIN AMERICA: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 550 LATIN AMERICA: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 551 LATIN AMERICA: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 552 LATIN AMERICA: CELL EXPANSION MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 553 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 554 LATIN AMERICA: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 555 LATIN AMERICA: MARKET, BY END USER, 2020–2025 (USD MILLION)
10.5.2 MIDDLE EAST & AFRICA
TABLE 556 MIDDLE EAST & AFRICA: CELL EXPANSION MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 557 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT, 2020–2025 (USD MILLION)
TABLE 558 MIDDLE EAST & AFRICA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 559 MIDDLE EAST & AFRICA: CELL EXPANSION CONSUMABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 560 MIDDLE EAST & AFRICA: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 561 MIDDLE EAST & AFRICA: CELL EXPANSION DISPOSABLES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 562 MIDDLE EAST & AFRICA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 563 MIDDLE EAST & AFRICA: CELL EXPANSION INSTRUMENTS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 564 MIDDLE EAST & AFRICA: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 565 MIDDLE EAST & AFRICA: CELL EXPANSION SUPPORTING EQUIPMENT MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 566 MIDDLE EAST & AFRICA: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 567 MIDDLE EAST & AFRICA: CELL EXPANSION BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 568 MIDDLE EAST & AFRICA: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 569 MIDDLE EAST & AFRICA: CELL EXPANSION MICROCARRIER BIOREACTORS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 570 MIDDLE EAST & AFRICA: MARKET, BY CELL TYPE, 2016–2019 (USD MILLION)
TABLE 571 MIDDLE EAST & AFRICA: MARKET, BY CELL TYPE, 2020–2025 (USD MILLION)
TABLE 572 MIDDLE EAST & AFRICA: HUMAN CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 573 MIDDLE EAST & AFRICA: HUMAN CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 574 MIDDLE EAST & AFRICA: STEM CELLS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 575 MIDDLE EAST & AFRICA: STEM CELLS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 576 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 577 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 578 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 579 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 286)
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS, 2019
FIGURE 21 SHARE OF COMPANIES IN THE CELL EXPANSION MARKET, 2019
11.3 COMPETITIVE SCENARIO
11.3.1 PRODUCT LAUNCHES AND APPROVALS
11.3.2 ACQUISITIONS
11.3.3 AGREEMENTS
11.3.4 PARTNERSHIPS
11.3.5 EXPANSIONS
11.4 COMPETITIVE LEADERSHIP MAPPING
11.4.1 VENDOR INCLUSION CRITERIA
11.4.2 VISIONARY LEADERS
11.4.3 INNOVATORS
11.4.4 DYNAMIC DIFFERENTIATORS
11.4.5 EMERGING COMPANIES
FIGURE 22 MNM DIVE-VENDOR COMPARISON MATRIX: CELL EXPANSION MARKET
12 COMPANY PROFILES (Page No. - 292)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 THERMO FISHER SCIENTIFIC, INC.
FIGURE 23 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
12.2 DANAHER
FIGURE 24 DANAHER CORPORATION: COMPANY SNAPSHOT
12.3 BECTON, DICKINSON AND COMPANY
FIGURE 25 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
12.4 LONZA
FIGURE 26 LONZA GROUP LTD: COMPANY SNAPSHOT
12.5 CORNING INCORPORATED
FIGURE 27 CORNING, INC: COMPANY SNAPSHOT
12.6 MERCK KGAA
FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT
12.7 SARTORIUS STEDIM BIOTECH
FIGURE 29 SARTORIUS STEDIM BIOTECH: COMPANY SNAPSHOT
12.8 GETINGE AB
FIGURE 30 GETINGE AB: COMPANY SNAPSHOT
12.9 TERUMO CORPORATION
FIGURE 31 TERUMO CORPORATION: COMPANY SNAPSHOT
12.10 MILTENYI BIOTEC
12.11 STEMCELL TECHNOLOGIES, INC.
12.12 SOLIDA BIOTECH GMBH
12.13 CELLEXUS
12.14 CELLGENIX GMBH
12.15 EPPENDORF AG
FIGURE 32 EPPENDORF: COMPANY SNAPSHOT
12.16 HIMEDIA LABORATORIES
12.17 KOHJIN BIO
12.18 PROMOCELL GMBH
12.19 PIERRE GUÉRIN
12.20 TAKARA BIO INC.
FIGURE 33 TAKARA BIO INC.: COMPANY SNAPSHOT
12.21 START-UP COMPANIES
12.21.1 REPROCELL INC.
12.21.2 IXCELLS BIOTECHNOLOGIES
12.21.3 NEUROMICS
12.21.4 G&G TECHNOLOGIES, INC.
12.21.5 CELLTAINER BIOTECH BV
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
13 ADJACENT & RELATED MARKETS (Page No. - 335)
13.1 INTRODUCTION
13.2 LIMITATIONS
13.3 3D CELL CULTURE MARKET
13.3.1 MARKET DEFINITION
13.3.2 MARKET OVERVIEW
13.3.3 3D CELL CULTURE MARKET, BY REGION
TABLE 580 3D CELL CULTURE MARKET, BY REGION, 2017–2024 (USD MILLION)
13.3.3.1 North America
TABLE 581 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
13.3.3.2 Europe
TABLE 582 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
13.3.3.3 Asia Pacific
TABLE 583 APAC: 3D CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
13.4 SINGLE-USE BIOREACTORS MARKET
13.4.1 MARKET DEFINITION
13.4.2 MARKET OVERVIEW
13.4.3 SINGLE-USE BIOREACTORS MARKET, BY REGION
TABLE 584 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2015–2022 (USD MILLION)
13.4.3.1 Europe
TABLE 585 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
13.4.3.2 North America
TABLE 586 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
13.4.3.3 Asia Pacific
TABLE 587 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
13.5 CELL ISOLATION MARKET
13.5.1 MARKET DEFINITION
13.5.2 MARKET OVERVIEW
13.5.3 CELL ISOLATION MARKET, BY REGION
TABLE 588 CELL ISOLATION MARKET, BY REGION, 2017–2024 (USD MILLION)
13.5.3.1 North America
TABLE 589 NORTH AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
13.5.3.2 Europe
TABLE 590 EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
13.5.3.3 Asia Pacific
TABLE 591 ASIA PACIFIC: CELL ISOLATION MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
13.6 CELL CULTURE MARKET
13.6.1 MARKET DEFINITION
13.6.2 MARKET OVERVIEW
13.6.3 CELL CULTURE MARKET, BY REGION
TABLE 592 CELL CULTURE MARKET, BY REGION, 2017–2024 (USD MILLION)
13.6.3.1 North America
TABLE 593 NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
13.6.3.2 Europe
TABLE 594 EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
13.6.3.3 Asia Pacific
TABLE 595 ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
14 APPENDIX (Page No. - 346)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
The study involved four major activities in estimating the current size of the cell expansion market. Exhaustive secondary research was done to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and sub-segments.
Secondary Research
The secondary sources referred for this research study include publications from government sources such as the World Health Organization (WHO), National Cancer Institute (NCI), Centre for Commercialization of Regenerative Medicine (CCRM), European Federation of Pharmaceutical Industries and Associations (EFPIA); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations. Secondary research was mainly used to obtain key information about the industry’s total pool of key players; market classification and segmentation according to industry trends to the bottom-most level; global market trends; and key developments by both public and private organizations in the cell expansion market.
Primary Research
Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (research institutes, biopharmaceutical companies) and supply sides (cell expansion products manufacturers and distributors).
The primaries interviewed for this study included experts from the industry, such as CEOs, VPs, directors, sales heads, and marketing managers of tier 1 and tier 2 companies engaged in offering cell expansion products across the globe; and administrators and research institutions. Approximately 70% of the primary interviews were conducted from the supply side, while 30% were conducted from the demand side. This primary data was collected through questionnaires, emails, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell expansion market. These methods were also used extensively to estimate the size of various subsegments in the market.
Bottom-Up Approach
The bottom-up procedure was adopted to arrive at the overall size of the cell expansion market from the revenue of key players (companies), their shares in the market, and their annual sales of cell expansion products.
Top-Down Approach
The overall cell expansion market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation by product, cell type, application, end user, and region) through percentage splits from secondary and primary research.
For the calculation of each type of specific market segment, the most appropriate immediate-parent market size was used for implementing the top-down approach. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Market shares were then estimated for top companies to verify the total market revenue arrived earlier in the bottom-up approach.
Data Triangulation
After arriving at the overall market size, from the market size estimation process explained above, the cell expansion market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the cell expansion industry.
Report Objectives
- To define, describe, and forecast the cell expansion market based on the product, cell type, application, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, and opportunities)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (RoW)
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as product launches, agreements, expansions, and acquisitions in the cell expansion market
- To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Available Customizations:
MarketsandMarkets offers the following customizations for this market report:
Company Information
- Profiling of additional market players (up to 3)
- Additional country-level analysis of sub-segments such as media, reagents, flow cytometers, and centrifuges.
Growth opportunities and latent adjacency in Cell Expansion Market